メーカー別の市場細分化では、レポートは次の企業をカバーしています- Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Cardinal Health
B. Braun Melsungen AG
Biosensors International Group Ltd.
C.R. Bard, Inc.
St. Jude Medical, Inc.
The Lubrizol Corporation
Terumo Corporation
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Type (2020-2025)
1.3.2 Plain Old Balloon Angioplasty (POBA)
1.3.3 Percutaneous Transluminal Angioplasty (PTA)
1.4 Market Segment by Application
1.4.1 Global Peripheral Intervention Drug-Eluting Devices Market Share by Application (2020-2025)
1.4.2 Drug-Eluting Balloons
1.4.3 Drug-Eluting Stents
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Peripheral Intervention Drug-Eluting Devices Production Value 2015-2025
2.1.2 Global Peripheral Intervention Drug-Eluting Devices Production 2015-2025
2.1.3 Global Peripheral Intervention Drug-Eluting Devices Capacity 2015-2025
2.1.4 Global Peripheral Intervention Drug-Eluting Devices Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2020-2025
2.2.1 Global Peripheral Intervention Drug-Eluting Devices Market Size CAGR of Key Regions
2.2.2 Global Peripheral Intervention Drug-Eluting Devices Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Peripheral Intervention Drug-Eluting Devices Capacity by Manufacturers
3.1.2 Global Peripheral Intervention Drug-Eluting Devices Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturers (2015-2019)
3.2.2 Peripheral Intervention Drug-Eluting Devices Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Peripheral Intervention Drug-Eluting Devices Market Concentration Ratio (CR5 and HHI)
3.3 Peripheral Intervention Drug-Eluting Devices Price by Manufacturers
3.4 Key Manufacturers Peripheral Intervention Drug-Eluting Devices Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Peripheral Intervention Drug-Eluting Devices Market
3.6 Key Manufacturers Peripheral Intervention Drug-Eluting Devices Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Plain Old Balloon Angioplasty (POBA) Production and Production Value (2015-2019)
4.1.2 Percutaneous Transluminal Angioplasty (PTA) Production and Production Value (2015-2019)
4.2 Global Peripheral Intervention Drug-Eluting Devices Production Market Share by Type
4.3 Global Peripheral Intervention Drug-Eluting Devices Production Value Market Share by Type
4.4 Peripheral Intervention Drug-Eluting Devices Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Peripheral Intervention Drug-Eluting Devices Consumption by Application
6 Production by Regions
6.1 Global Peripheral Intervention Drug-Eluting Devices Production (History Data) by Regions 2015-2019
6.2 Global Peripheral Intervention Drug-Eluting Devices Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Peripheral Intervention Drug-Eluting Devices Production Growth Rate 2015-2019
6.3.2 United States Peripheral Intervention Drug-Eluting Devices Production Value Growth Rate 2015-2019
6.3.3 Key Players in United States
6.3.4 United States Peripheral Intervention Drug-Eluting Devices Import & Export
6.4 European Union
6.4.1 European Union Peripheral Intervention Drug-Eluting Devices Production Growth Rate 2015-2019
6.4.2 European Union Peripheral Intervention Drug-Eluting Devices Production Value Growth Rate 2015-2019
6.4.3 Key Players in European Union
6.4.4 European Union Peripheral Intervention Drug-Eluting Devices Import & Export
6.5 China
6.5.1 China Peripheral Intervention Drug-Eluting Devices Production Growth Rate 2015-2019
6.5.2 China Peripheral Intervention Drug-Eluting Devices Production Value Growth Rate 2015-2019
6.5.3 Key Players in China
6.5.4 China Peripheral Intervention Drug-Eluting Devices Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Peripheral Intervention Drug-Eluting Devices Consumption by Regions
7.1 Global Peripheral Intervention Drug-Eluting Devices Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Peripheral Intervention Drug-Eluting Devices Consumption by Type
7.2.2 United States Peripheral Intervention Drug-Eluting Devices Consumption by Application
7.3 European Union
7.3.1 European Union Peripheral Intervention Drug-Eluting Devices Consumption by Type
7.3.2 European Union Peripheral Intervention Drug-Eluting Devices Consumption by Application
7.4 China
7.4.1 China Peripheral Intervention Drug-Eluting Devices Consumption by Type
7.4.2 China Peripheral Intervention Drug-Eluting Devices Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Peripheral Intervention Drug-Eluting Devices Consumption by Type
7.5.2 Rest of World Peripheral Intervention Drug-Eluting Devices Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Medtronic plc
8.1.1 Medtronic plc Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
8.1.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
8.1.5 Medtronic plc Recent Development
8.2 Boston Scientific Corporation
8.2.1 Boston Scientific Corporation Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
8.2.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
8.2.5 Boston Scientific Corporation Recent Development
8.3 Abbott Laboratories
8.3.1 Abbott Laboratories Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
8.3.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
8.3.5 Abbott Laboratories Recent Development
8.4 Cardinal Health
8.4.1 Cardinal Health Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
8.4.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
8.4.5 Cardinal Health Recent Development
8.5 B. Braun Melsungen AG
8.5.1 B. Braun Melsungen AG Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
8.5.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
8.5.5 B. Braun Melsungen AG Recent Development
8.6 Biosensors International Group Ltd.
8.6.1 Biosensors International Group Ltd. Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
8.6.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
8.6.5 Biosensors International Group Ltd. Recent Development
8.7 C.R. Bard, Inc.
8.7.1 C.R. Bard, Inc. Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
8.7.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
8.7.5 C.R. Bard, Inc. Recent Development
8.8 St. Jude Medical, Inc.
8.8.1 St. Jude Medical, Inc. Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
8.8.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
8.8.5 St. Jude Medical, Inc. Recent Development
8.9 The Lubrizol Corporation
8.9.1 The Lubrizol Corporation Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
8.9.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
8.9.5 The Lubrizol Corporation Recent Development
8.10 Terumo Corporation
8.10.1 Terumo Corporation Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
8.10.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
8.10.5 Terumo Corporation Recent Development
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Peripheral Intervention Drug-Eluting Devices Capacity, Production Forecast 2020-2025
9.1.2 Global Peripheral Intervention Drug-Eluting Devices Production Value Forecast 2020-2025
9.2 Market Forecast by Regions
9.2.1 Global Peripheral Intervention Drug-Eluting Devices Production and Value Forecast by Regions 2020-2025
9.2.2 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Regions 2020-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Peripheral Intervention Drug-Eluting Devices Production Forecast by Type
9.7.2 Global Peripheral Intervention Drug-Eluting Devices Production Value Forecast by Type
9.8 Consumption Forecast by Application
